Scientist II/III (master or Bachelor degree level)
with strong interpersonal communication skills to join the talented Cancer Immunology & Immune Modulation (CI & IM) Research Group at Boehringer Ingelheim’s US research facility in Ridgefield, CT. The successful candidate will work within the CI&IM in vivo pharmacology group to advance both exploratory and drug candidate discovery programs and provide target discovery/validation, in-vivo efficacy, mechanism of action (MOA) and pharmacodynamic data essential to drive projects into clinic...
Source: mitbbs.com